Literature DB >> 25785780

AcpM, the meromycolate extension acyl carrier protein of Mycobacterium tuberculosis, is activated by the 4'-phosphopantetheinyl transferase PptT, a potential target of the multistep mycolic acid biosynthesis.

Oren Zimhony1, Alon Schwarz, Maria Raitses-Gurevich, Yoav Peleg, Orly Dym, Shira Albeck, Yigal Burstein, Zippora Shakked.   

Abstract

Modification of acyl carrier proteins (ACP) or domains by the covalent binding of a 4'-phosphopantetheine (4'-PP) moiety is a fundamental condition for activation of fatty acid synthases (FASes) and polyketide synthases (PKSes). Binding of 4'-PP is mediated by 4' phosphopantetheinyl transfersases (PPTases). Mycobacterium tuberculosis (Mtb) possesses two essential PPTases: acyl carrier protein synthase (Mtb AcpS), which activates the multidomain fatty acid synthase I (FAS I), and Mtb PptT, an Sfp-type broad spectrum PPTase that activates PKSes. To date, it has not been determined which of the two Mtb PPTases, AcpS or PptT, activates the meromycolate extension ACP, Mtb AcpM, en route to the production of mycolic acids, the main components of the mycobacterial cell wall. In this study, we tested the enzymatic activation of a highly purified Mtb apo-AcpM to Mtb holo-AcpM by either Mtb PptT or Mtb AcpS. By using SDS-PAGE band shift assay and mass spectrometry analysis, we found that Mtb PptT is the PPTase that activates Mtb AcpM. We measured the catalytic activity of Mtb PptT toward CoA, using an activation assay of a blue pigment synthase, BpsA (a nonribosomal peptide synthase, NRPS). BpsA activation by Mtb PptT was inhibited by Mtb apo-AcpM through competition for CoA, in accord with Mtb AcpM activation. A structural model of the putative interaction between Mtb PptT and Mtb AcpM suggests that both hydrophobic and electrostatic interactions stabilize this complex. To conclude, activation of Mtb AcpM by Mtb PptT reveals a potential target of the multistep mycolic acid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25785780     DOI: 10.1021/bi501444e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Structural insights into phosphopantetheinyl hydrolase PptH from Mycobacterium tuberculosis.

Authors:  John Mosior; Ronnie Bourland; Shivatheja Soma; Carl Nathan; James Sacchettini
Journal:  Protein Sci       Date:  2020-01-20       Impact factor: 6.725

2.  Cryo-EM Structures and Regulation of Arabinofuranosyltransferase AftD from Mycobacteria.

Authors:  Yong Zi Tan; Lei Zhang; José Rodrigues; Ruixiang Blake Zheng; Sabrina I Giacometti; Ana L Rosário; Brian Kloss; Venkata P Dandey; Hui Wei; Richard Brunton; Ashleigh M Raczkowski; Diogo Athayde; Maria João Catalão; Madalena Pimentel; Oliver B Clarke; Todd L Lowary; Margarida Archer; Michael Niederweis; Clinton S Potter; Bridget Carragher; Filippo Mancia
Journal:  Mol Cell       Date:  2020-05-07       Impact factor: 17.970

3.  Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Authors:  Elaine Ballinger; John Mosior; Travis Hartman; Kristin Burns-Huang; Ben Gold; Roxanne Morris; Laurent Goullieux; Isabelle Blanc; Julien Vaubourgeix; Sophie Lagrange; Laurent Fraisse; Stéphanie Sans; Cedric Couturier; Eric Bacqué; Kyu Rhee; Sarah M Scarry; Jeffrey Aubé; Guangbin Yang; Ouathek Ouerfelli; Dirk Schnappinger; Thomas R Ioerger; Curtis A Engelhart; Jennifer A McConnell; Kathrine McAulay; Allison Fay; Christine Roubert; James Sacchettini; Carl Nathan
Journal:  Science       Date:  2019-02-01       Impact factor: 47.728

4.  Mass spectral determination of phosphopantetheinylation specificity for carrier proteins in Mycobacterium tuberculosis.

Authors:  James Jung; Ghader Bashiri; Jodie M Johnston; Edward N Baker
Journal:  FEBS Open Bio       Date:  2016-10-24       Impact factor: 2.693

5.  Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance.

Authors:  Suwarna P Gample; Sonia Agrawal; Dhiman Sarkar
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

6.  Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.

Authors:  Alemayehu Godana Birhanu; Solomon Abebe Yimer; Shewit Kalayou; Tahira Riaz; Ephrem Debebe Zegeye; Carol Holm-Hansen; Gunnstein Norheim; Abraham Aseffa; Markos Abebe; Tone Tønjum
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

7.  Mycobacterial acyl carrier protein suppresses TFEB activation and upregulates miR-155 to inhibit host defense.

Authors:  Seungwha Paik; Kyeong Tae Kim; In Soo Kim; Young Jae Kim; Hyeon Ji Kim; Seunga Choi; Hwa-Jung Kim; Eun-Kyeong Jo
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

8.  Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis.

Authors:  Joanna C Evans; Carolina Trujillo; Zhe Wang; Hyungjin Eoh; Sabine Ehrt; Dirk Schnappinger; Helena I M Boshoff; Kyu Y Rhee; Clifton E Barry; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2016-10-05       Impact factor: 5.084

9.  Phosphopantetheinyl transferase binding and inhibition by amidino-urea and hydroxypyrimidinethione compounds.

Authors:  Coralie Carivenc; Laurent Maveyraud; Claire Blanger; Stéphanie Ballereau; Coralie Roy-Camille; Minh Chau Nguyen; Yves Génisson; Christophe Guilhot; Christian Chalut; Jean-Denis Pedelacq; Lionel Mourey
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

10.  In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas.

Authors:  Samantha Ottavi; Sarah M Scarry; John Mosior; Yan Ling; Julia Roberts; Amrita Singh; David Zhang; Laurent Goullieux; Christine Roubert; Eric Bacqué; H Rachel Lagiakos; Jeremie Vendome; Francesca Moraca; Kelin Li; Andrew J Perkowski; Remya Ramesh; Matthew M Bowler; William Tracy; Victoria A Feher; James C Sacchettini; Ben S Gold; Carl F Nathan; Jeffrey Aubé
Journal:  J Med Chem       Date:  2022-01-19       Impact factor: 8.039

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.